To view this email as a web page, click here.
 
FDA ACTIONS
 
FDA approves Bayer's Bluetooth-enabled auto-injector for multiple sclerosis
FDA has approved a supplemental Biologics License Application for Bayer's myBETAapp and BETACONNECT Navigator for people living with relapsing-remitting multiple sclerosis.
Read more
 
New antibiotic approved for acute bacterial skin infections
FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.
Read more
 
FDA to drug maker: Pull opioid pain drug
Potential public health consquences prompts FDA to request removal of opioid pain medication.
Read more
 
SURVEY
 
State of the Industry Survey 2017
Take three minutes to answer our State of the Industry Survey. As a thank-you to survey-takers, when the survey closes, we will hold a drawing to give away not one, but two $200 Visa gift cards.
Take survey
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.